| Divergence is led by a strong team of scientists and managers, an
outstanding Board of Directors, and a world-class Scientific Advisory Board.
The Board of Directors includes John McCarter,
President of Chicago's Field Museum and former President of DeKalb Genetics; and Mark
Wong, CEO of Agrivida, Inc. and former CEO of Emergent Genetics, Agracetus,
and other agricultural biotechnology companies.
See Board of Directors
The Scientific Advisory Board includes Craig Mello,
2006 recipient of the Nobel Prize in Physiology or Medicine for his co-discovery of RNA-interference;
Sean Eddy, a Howard Hughes Investigator and developer of the Pfam database; and Gil Omenn,
former Executive Vice President for Medical Affairs and CEO of the University of Michigan
Health System. Divergence has a close working relationship with both boards.
See Scientific Advisory Board
Management includes Derek Rapp, former Head of Mergers and Acquisitions
and Licensing for Monsanto; and Jim McCarter, an adjunct faculty member of Washington University and leading
expert on parasite genomes.
See Management & Scientists
|